Medica Group (LON:MGP)‘s stock had its “buy” rating reissued by equities research analysts at Berenberg Bank in a report issued on Monday. They presently have a GBX 230 ($3.18) price target on the stock. Berenberg Bank’s price target indicates a potential upside of 49.74% from the stock’s previous close.

Separately, Investec lowered their price objective on shares of Medica Group from GBX 239 ($3.30) to GBX 210 ($2.90) and set a “buy” rating on the stock in a research report on Monday.

Medica Group (LON:MGP) opened at GBX 153.60 ($2.12) on Monday. Medica Group has a 1 year low of GBX 135 ($1.87) and a 1 year high of GBX 242 ($3.34).

WARNING: “Medica Group’s (MGP) “Buy” Rating Reaffirmed at Berenberg Bank” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at

About Medica Group

Medica Group PLC is a United Kingdom-based company, which is engaged in the provision of teleradiology services. The Company offers an information technology (IT) platform that provides linkage between a hospital’s radiology information system (RIS) and consultant radiologists who contract with the Company.

Receive News & Ratings for Medica Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medica Group and related companies with's FREE daily email newsletter.